Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.780
-0.140 (-7.29%)
At close: Oct 31, 2025, 4:00 PM EDT
1.760
-0.020 (-1.12%)
After-hours: Oct 31, 2025, 4:17 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $83.89 million as of October 31, 2025. Its market cap has decreased by -19.36% in one year.
Market Cap
83.89M
Enterprise Value
34.51M
1-Year Change
-19.36%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $83.89M, a decrease of -89.57%. That is a compound annual growth rate of -38.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 90.49M | 2.72% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.14B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |